Showing 18,081 - 18,100 results of 46,288 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 0.86s Refine Results
  1. 18081

    Simulating non-small cell lung cancer with a multiscale agent-based model-2 by Zhihui Wang (88248)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "Simulating non-small cell lung cancer with a multiscale agent-based model"</p><p>http://www.tbiomed.com/content/4/1/50</p><p>Theoretical Biology & Medical Modelling 2007;4():50-50.…”
  2. 18082

    Dynamic cerebral autoregulation is impaired in Veterans with Gulf War Illness: A case-control study by Michael J. Falvo (4437265)

    Published 2018
    “…Dynamic autoregulation was significantly lower in GWI+ than GWI- both for autoregulatory index (2.99±1.5 vs 4.50±1.5, <i>p</i> = 0.017). In addition, we observed greater decreases in CBF velocity both at the nadir after standing (-18.5±6.0 vs -9.8±4.9%, <i>p</i> = 0.001) and during steady state standing (-5.7±7.1 vs -1.8±3.2%, <i>p</i> = 0.042). …”
  3. 18083
  4. 18084

    Supplementary Material for: Surfactant Treatment of Late Preterm Infants during Emergency Transport: A Retrospective, Observational Study by Cavallin F. (11448277)

    Published 2021
    “…<b><i>Results:</i></b> Surfactant was administered to 155/303 neonates (51.1%) at 3 different time points: at a referring hospital (50 neonates), when the transport team arrived (25 neonates), or at a referral hospital (80 neonates). …”
  5. 18085

    Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients by Sana Mohsin (19773969)

    Published 2024
    “…</p> <p><b>Results:</b> 3 cohort studies were identified, analyzing 2817 patients. Results display a significant reduction in overall mortality [RR = 0.52 (0.33–0.82); <i>p</i> = 0.005; I<sup>2</sup>= 32%], HF hospitalization [RR = 0.20 (0.04–1.02); <i>p</i> = 0.05; I<sup>2</sup>= 0%] and no significant reduction in HF incidence [RR = 0.50 (0.20–1.16); <i>p</i> = 0.11, I<sup>2</sup>= 0%].…”
  6. 18086

    Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease by Yagahira E. Castro-Sesquen (284439)

    Published 2014
    “…The nanoparticles concentrate <i>T. cruzi</i> antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%–98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%–57.26%). …”
  7. 18087

    Data_Sheet_1_Mindfulness Training for Primary Care for Portuguese-Speaking Immigrants: A Pilot Study.docx by Marcelo Trombka (11411288)

    Published 2021
    “…All survey finishers would recommend the program to a friend, found the program helpful, and rated the overall program as “very good” or “excellent,” and 93% would participate again, with satisfaction mean scores between 4.6 and 5 (Likert scale 0–5). …”
  8. 18088

    Rescue the Failed Half-ZFN by a Sensitive Mammalian Cell-Based Luciferase Reporter System by Weifeng Zhang (134361)

    Published 2012
    “…Lastly, site-specific genome editing by hPGRN ZFNs generated by this system was confirmed by sequencing, and the PGRN knock-out cell line showed significantly decreased cell growth compared with the control. Our system will provide a valuable tool for further optimizing the nucleases with regard to specificity and cytotoxicity.…”
  9. 18089
  10. 18090

    Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial by Beatrice A. Golomb (140574)

    Published 2015
    “…</p><p>Trial Registration</p><p>Clinicaltrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT00330980" target="_blank">NCT00330980</a></p></div>…”
  11. 18091
  12. 18092

    Table_2_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.XLSX by Jan Vollert (5099921)

    Published 2022
    “…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”
  13. 18093

    Table_1_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.xlsx by Jan Vollert (5099921)

    Published 2022
    “…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”
  14. 18094

    Neutralization of point mutants of B.1.351 and D614G spike-pseudotyped lentiviral particles by convalescent plasmas from B.1.351 and early 2020-infected individuals. by Allison J. Greaney (11046384)

    Published 2022
    “…<b>(B)</b> The fold-decrease in neutralization for samples shown in <b><a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.g005" target="_blank">Fig 5</a></b>, with the addition of previously measured neutralization by samples from 6 early 2020 convalescent individuals collected approximately 100 days post-symptom onset [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.ref038" target="_blank">38</a>]. …”
  15. 18095
  16. 18096
  17. 18097

    Data_Sheet_1_Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study.PDF by Michal Židó (12641944)

    Published 2022
    “…During the targeted analysis, a significant decrease in arginine and histidine and a less significant decrease in the levels of asparagine, leucine/isoleucine, and tryptophan, together with a significant increase of palmitic acid in the patient group, were found.…”
  18. 18098

    A reduction in brain mass and cortical volume seen in the adult <i>Cln6<sup>nclf</sup></i> mouse. by Jeremy P. Morgan (479017)

    Published 2013
    “…<p>Brain mass was assessed in the <i>Cln6<sup>nclf</sup></i>, as a decrease in brain mass is often seen in vLINCL patients. …”
  19. 18099
  20. 18100